Advancing research in pregnancy during COVID-19: Missed opportunities and momentum in the US

Elana F Jaffe; Anne Drapkin Lyerly; Ilona T Goldfarb

doi:10.1016/j.medj.2021.04.019

Advancing research in pregnancy during COVID-19: Missed opportunities and momentum in the US

Med. 2021 May 14;2(5):460-464. doi: 10.1016/j.medj.2021.04.019.

Authors

Elana F Jaffe¹, Anne Drapkin Lyerly¹, Ilona T Goldfarb²

Affiliations

¹ Center for Bioethics, Department of Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
² Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

Abstract

Pregnant people's exclusion from COVID-19 vaccine research highlights both the harms of excluding pregnant people from clinical trials and the growing public support for their equitable inclusion. Protectionary tendencies must be challenged for the sake of progress. The COVID-19 pandemic presents an opportunity to translate recognition of an unjust paradigm into action.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 Vaccines / therapeutic use
COVID-19* / epidemiology
Female
Humans
Pandemics / prevention & control
Pregnancy
SARS-CoV-2

Substances

COVID-19 Vaccines

Abstract

Publication types

MeSH terms

Substances

Grants and funding